Aenitis Technologies Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 17
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $1.23M
Latest Deal Amount
  • Investors
  • 6

Aenitis Technologies General Information

Description

Developer of a medical device intended to offer assistance for cell therapy preparations. The company's devices focus on cell therapy units and blood banks' challenges by developing bioprocessing medical devices dedicated to cell therapy manufacturing issues including cell sorting, cell washing and cell isolation, enabling the healthcare industry to get acoustic preparation support for cell therapies.

Contact Information

Website
www.aenitis.fr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Services
Primary Office
  • 1 avenue Claude Vellefaux
  • Saint Louis Hospital, Bâtiment Jean Bernard
  • 75010 Paris
  • France

Aenitis Technologies Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aenitis Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Grant 02-Dec-2019 $1.23M 00.000 Completed Generating Revenue
4. Early Stage VC 30-Nov-2017 00.00 00.000 000.00 Completed Generating Revenue
3. Angel (individual) 13-Jul-2016 000.00 00.000 00.000 Completed Startup
2. Seed Round 04-May-2015 $1.09M $1.09M 00.000 Completed Startup
1. Accelerator/Incubator 01-Sep-2013 Completed Startup
To view Aenitis Technologies’s complete valuation and funding history, request access »

Aenitis Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 00,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
Ordinary 55,850 $1.174274 $21.03 $21.03 1x $21.03 28.16%
To view Aenitis Technologies’s complete cap table history, request access »

Aenitis Technologies Executive Team (6)

Name Title Board Seat Contact Info
Emmanuel Vincent Co-Founder, Chief Executive Officer & Advisor
Jacky Harrouet Chief Financial Officer
Fabrice Verjus Ph.D Chef Technology and Regulatory Officer
Olivier Quenaudon Chief Technology Officer
Mauricio Hoyos Co-founder & Scientific Advisor
You’re viewing 5 of 6 executive team members. Get the full list »

Aenitis Technologies Board Members (1)

Name Representing Role Since
Philippe Tramoy Seventure Partners Strategic Board Member 000 0000
To view Aenitis Technologies’s complete board members history, request access »

Aenitis Technologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aenitis Technologies Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EIT Health Accelerator/Incubator 000 0000 000000 0
Horizon 2020 Government Minority 000 0000 000000 0
Weaving Invest Venture Capital Minority 000 0000 000000 0
FIST SA Other Minority 000 0000 000000 0
Seventure Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »